Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens

International Journal of Toxicology

Volumn 31, Issue 2, 2012, Pages 166-174

  Kalam, Yasmean ^a   Graudins, Andis ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

animal study; levosimendan; overdose; poisoning; propranolol; toxicology

Indexed keywords

ADRENALIN; LEVOSIMENDAN; PROPRANOLOL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MEGADOSE; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; QRS COMPLEX; RAT; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; HYDRAZONES; MALE; PROPRANOLOL; PYRIDAZINES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 84861852107     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581811435366     Document Type: Article

References (28)

1. Bailey B. Glucagon in β-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol. 2003 ; 41 (5). 595-602 (Pubitemid 37102385)
2. Holger J, Engebretsen K, Obetz C, Kleven T, Harris C. A comparison of vasopressin and glucagon in beta-blocker induced toxicity. Clin Toxicol. 2006 ; 44 (1). 45-51 (Pubitemid 44112963)
3. Kerns Ii W, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute (beta)-blocker toxicity. Ann Emerg Med. 1997 ; 29 (6). 748-757 (Pubitemid 27232757)
4. Mansell PI. Glucagon in the management of deliberate self-poisoning with propranolol. Archiv Emerg Med. 1990 ; 7 (3). 238-240
5. Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and (beta)-blocker poisoning. Toxicol Rev. 2004 ; 23 (4). 215-222 (Pubitemid 41018275)
6. Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W. Levosimendan improves postresuscitation outcomes in a rat model of CPR. J Lab Clin Med. 2005 ; 146 (5). 256-261 (Pubitemid 41464402)
7. Huang L, Weil MH, Tang W, Sun S, Wang J. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med. 2005 ; 33 (3). 487-491 (Pubitemid 40365546)
8. Lehtonen L. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure. Curr Heart Fail Rep. 2004 ; 1 (3). 136-144
9. Graudins A, Najafi J, Rur-Sc MPM. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity. Clin Toxicol. 2008 ; 46 (1). 50-56
10. Najafi JM, Graudins A. Norepinephrine co-administered with levosimendan does not reverse hypotension in a rodent model experimental verapamil poisoning [abstract]. Emerg Med Australas. 2007 ; 19 (suppl1). A19 - A20
11. Graudins A, Wong KKL. Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe Verapamil poisoning. J Med Toxicol. 2010 ; 6 (2). 85-93
12. Kurola J, Leppikangas H, Magga J, et al. Effect of levosimendan in experimental verapamil-induced myocardial depression. Scand J Trauma Resusc Emerg Med. 2010 ; 18: 12
13. Leppikangas H, Ruokonen E, Rutanen J, Kiviniemi V, Lindgren L, Kurola J. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study. Ann Emerg Med. 2009 ; 54 (6). 811-817
14. Lugassy DM, Stefan A, Dexeus D, Hoffman RS, Nelson LS. In response to Leppikangas H, et al, Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study. Ann Emerg Med. 2010 ; 55 (5). 486
15. Kalam Y, Graudins A. Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity. Hum Exp Toxicol. 2012 ;.
16. Hill MA, Larkins RG. Alterations in distribution of cardiac output in experimental diabetes in rats. Am J Physiol Heart Circ Physiol. 1989 ; 257 (2). 26
17. Goldfrank L, Flamenbaum M, Lewin N, Howland M, Hoffman R, Nelson L Goldfrank's Toxicologic Emergencies. New York, NY: McGraw-Hill ; 2002.
18. Kerns Ii W. Management of (beta)-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007 ; 25 (2). 309-331
19. Lehtonen LA.. Levosimendan: aparenteralcalcium- sensitisingdrugwithadditionalvasodilatoryproperties. Expert Opin Investig Drugs. 2001 ; 10 (5). 955-970
20. Osthoff M, Bernsmeier C, Marsch SC, Hunziker PR. Levosimendan as treatment option in severe verapamil intoxication: a case report and review of the literature. Case Report Med. 2010 ; 2010.
21. Varpula T. Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer. Anesth Analg. 2009 ; 108 (3). 790-792
22. Nieminen MS. Levosimendan compared with dobutamine in low output patients. Minerva Anesthesiol. 2003 ; 69 (4). 258-263 (Pubitemid 41750911)
23. Frishman W, Silverman R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects. Am Heart J. 1979 ; 97 (6). 797-807 (Pubitemid 10180449)
24. Sasyniuk BI, Jhamandas V, Valois M. Experimental amitriptylline intoxication: treatment of cardiac toxicity with sodium bicarbonate. Ann Emerg Med. 1986 ; 15 (9). 1052-1059 (Pubitemid 16017764)
25. Pentel P, Benowitz N. Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats. J Pharmacol Exp Ther. 1984 ; 230 (1). 12-19 (Pubitemid 14097652)
26. Cleland JGF. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure. Expert Rev Cardiovasc Ther. 2004 ; 2 (1). 9-19 (Pubitemid 38678754)
27. Earl G. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure. Ann Pharmacother. 2005 ; 39 (11). 1888-1896 (Pubitemid 41527702)
28. Buelke Sam J, Holson JF, Bazare JJ, Young JF. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci. 1978 ; 28 (2). 157-162 (Pubitemid 8343548)